Metabolite details
Reactome pathways
- R-HSA-1430728 - Metabolism
- R-HSA-156580 - Phase II - Conjugation of compounds
- R-HSA-156582 - Acetylation
- R-HSA-211859 - Biological oxidations
Observed in studies
- New insights into the responses of soil microorganisms to polycyclic aromatic hydrocarbon stress by combining enzyme activity and sequencing analysis with metabolomics.
- Distribution of RESV and its metabolite peaks in mouse tissues after oral and skin administration
- Bioplatforms Australia: Antibiotic Resistant Sepsis Pathogens Framework Initiative (Escherichia coli assays)
- Human age-declined saliva metabolic markers determined by LC-MS
- Metabolic Dynamics of In Vitro CD8+ T Cell Activation.
- Global analysis of plasma lipidomics reveals altered lipid signatures in patients with osteonecrosis of the femoral head
- Metabolomic profiling reveals the effects of early-life lactoferrin intervention on protein synthesis, energy production and antioxidative capacity in the liver of suckling piglets
- Multi‐omics analysis of xylem sap uncovers dynamic modulation of poplar defenses by ammonium and nitrate
- Bioplatforms Australia: Antibiotic Resistant Sepsis Pathogens Framework Initiative (Streptococcus pneumoniae assays)
- Bioplatforms Australia: Antibiotic Resistant Sepsis Pathogens Framework Initiative (Streptococcus pyogenes assays)
- Multi-Omics Analysis Reveals Disturbance of Nanosecond Pulsed Electric Field in the Serum Metabolic Spectrum and Gut Microbiota
- Integrated Analyses of the Gut Microbiota, Intestinal Permeability and Serum Metabolome Phenotype in Rats with Alcohol Withdrawal Syndrome
- A Phosphate starvation response gene (psr1-like) is present in Micromonas pusilla and other marine algae and coordinates the metabolic response to phosphate deficiency
- Anti-anemia drug FG4592 retards the AKI to CKD transition by improving vascular regeneration and anti-oxidative capability (day 10)
- Analysis of Growth Phases of Enterotoxigenic Escherichia coli Reveals a Distinct Transition Phase before Entry into Early Stationary Phase with Shifts in Tryptophan, Fucose, and Putrescine Metabolism and Degradation of Neurotransmitter Precursors
- Distinct succinate modifying products are clinically diagnostic and prognostic biomarkers for fumarate hydratase deficient renal cell carcinoma
- Diallyl disulfide (DADS) ameliorates intestinal Candida albicans infection by modulating the gut microbiota and metabolites and providing intestinal protection in mice
- Long-term low-dose ionizing radiation induced chromosome-aberration-specific metabolic phenotype changes in radiation workers
- Metabolic profilings of rat INS-1 β-cells under changing levels of essential amino acids
- Limited nutrient availability in the tumor microenvironment renders pancreatic tumors sensitive to allosteric IDH1 inhibitors
- Interaction between Cervical Microbiota and Host Gene Regulation in Caesarean Section Scar Diverticulum
- Metabolic disorder and intestinal microflora dysbiosis in chronic inflammatory demyelinating polyradiculoneuropathy
- Flow cytometry has a significant impact on the cellular metabolome (CE-MS assay)
- PatA mediates biofilm formation and drugs resistance through regulating the synthesis of glycolipids and lipids in mycobacterium PatA mediates a novel mycolic acid synthesis pathway and regulates biofilm formation in mycobacterium
- Unraveling the metabolic effects of benzophenone-3 on the endosymbiotic dinoflagellate Cladocopium goreaui
- Genetic mapping and molecular mechanism behind color variation in the Asian vine snake
- Unexpected similarities between the Schizosaccharomyces and human blood metabolomes, and novel human metabolites (Blood fraction)
- Unexpected similarities between the Schizosaccharomyces and human blood metabolomes, and novel human metabolites (Blood plasma and RBC fractions)
- Changing environments and genetic variation: inbreeding does not compromise short-term physiological responses
Observed in differential profiles
- Low_Contamination_vs_High_Contamination
- Control_Oral_Blood_vs_RESV_Oral_Blood
- RPMI_B36_vs_Pooled_Sera_B36
- Old_vs_Young
- G3_Experimental_Sample_0h_vs_G11_Experimental_Sample_96h
- Control_vs_AONFH_Stage_III_IV
- Control_Day_8_vs_Lactoferrin_Day_8
- Ammonium_Low_vs_Ammonium_High
- G1_Pooled_Sera_Blood_4559_vs_G2_RPMI_Glucose_Blood_4559
- G1_RPMI_modified_Blood_M1T1_5448_vs_G2_Pooled_sera_Blood_M1T1_5448
- Control_vs_nsPEF_7_day
- Alcohol_Treatment_vs_Control
- Intracellular_vs_Extracellular
- Intracellular_vs_Extracellular
- Sham_vs_UIR
- E1777_Intracellular_MidLog_vs_E1777_Intracellular_EarlyStationary
- Normal_control_no_tumor_vs_FH_deficient_RCC
- G1_PBS_vs_G2_DSS
- LLIR_vs_Control
- G1_Control_vs_G2_Arginine_Addition
- Wild_Type_vs_Gene_Knockout
- Control_vs_CSD
- CIDP_patient_vs_healthy_control
- Ctrl_vs_Ab
- wild_type_vs_patA_deletion
- Control_vs_BP3_Low_Concentration
- Yellow_Skin_vs_Green_Skin
- Human_Blood_vs_Human_Plasma
- Human_Blood_vs_Human_Plasma
- Inbreeding_Growth_Chamber_0_day_vs_Inbreeding_Growth_Chamber_92_day
- Blood_vs_Plasma